ProShare Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $373K | Buy |
11,812
+247
| +2% | +$7.81K | ﹤0.01% | 1290 |
|
|
2025
Q1 | $384K | Sell |
11,565
-2,625
| -18% | -$87.1K | ﹤0.01% | 1243 |
|
|
2024
Q4 | $488K | Buy |
14,190
+4,534
| +47% | +$156K | ﹤0.01% | 1285 |
|
|
2024
Q3 | $386K | Buy |
9,656
+1,197
| +14% | +$47.9K | ﹤0.01% | 1301 |
|
|
2024
Q2 | $255K | Sell |
8,459
-2,029
| -19% | -$61.2K | ﹤0.01% | 1401 |
|
|
2024
Q1 | $352K | Buy |
10,488
+684
| +7% | +$23K | ﹤0.01% | 1317 |
|
|
2023
Q4 | $317K | Buy |
9,804
+850
| +9% | +$27.5K | ﹤0.01% | 1336 |
|
|
2023
Q3 | $293K | Buy |
8,954
+2
| +0% | +$66 | ﹤0.01% | 1217 |
|
|
2023
Q2 | $315K | Buy |
8,952
+924
| +12% | +$32.5K | ﹤0.01% | 1245 |
|
|
2023
Q1 | $262K | Sell |
8,028
-1,116
| -12% | -$36.4K | ﹤0.01% | 1284 |
|
|
2022
Q4 | $504K | Buy |
9,144
+471
| +5% | +$26K | ﹤0.01% | 960 |
|
|
2022
Q3 | $384K | Buy |
8,673
+467
| +6% | +$20.7K | ﹤0.01% | 1012 |
|
|
2022
Q2 | $400K | Sell |
8,206
-2,990
| -27% | -$146K | ﹤0.01% | 1040 |
|
|
2022
Q1 | $544K | Sell |
11,196
-2,772
| -20% | -$135K | ﹤0.01% | 1234 |
|
|
2021
Q4 | $595K | Buy |
+13,968
| New | +$595K | ﹤0.01% | 1337 |
|